Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/5/2025

Sepsis-Induced Purpura Fulminans Management

Initial Management

  • The Society of Critical Care Medicine recommends beginning immediate broad-spectrum antibiotics within the first hour of recognition of septic shock 1
  • For E. coli sepsis with purpura fulminans, the Infectious Diseases Society of America suggests using meropenem, imipenem/cilastin, or piperacillin/tazobactam as first-line therapy 2
  • Consider combination therapy with an aminoglycoside for severe sepsis, as recommended by the American College of Chest Physicians 2, 1
  • Obtain at least two sets of blood cultures before starting antibiotics, as advised by the Infectious Diseases Society of America 1

Hemodynamic Support

  • The American College of Cardiology recommends administering aggressive fluid resuscitation with crystalloids or colloids targeting mean arterial pressure ≥65 mmHg 3, 1
  • Target central venous pressure 8-12 mmHg and urinary output ≥0.5 ml/kg/h, as suggested by the Society of Critical Care Medicine 2, 3
  • If fluid resuscitation fails to restore adequate blood pressure, initiate vasopressors, such as norepinephrine, as recommended by the American College of Chest Physicians 3, 4

Specific Management for Purpura Fulminans

Blood Product Support

  • Target hemoglobin levels between 8-9 g/dl during acute phase, as recommended by the American Association of Blood Banks 3
  • Consider higher hemoglobin targets if clinically indicated or if central venous oxygen saturation is low, as suggested by the Society of Critical Care Medicine 4
  • Use plasma therapies to correct sepsis-induced thrombotic disorders, including DIC and thrombotic microangiopathy, as advised by the American College of Chest Physicians 4

Surgical Considerations

  • Source control, such as drainage of any purulent collections, should be performed within the first 12 hours if feasible, as recommended by the Surgical Infection Society 5

Monitoring and Ongoing Care

  • Perform daily reassessment of antimicrobial therapy for potential de-escalation once culture results are available, as suggested by the Infectious Diseases Society of America 1
  • Continue broad-spectrum antibiotics for 7-10 days, depending on clinical response, as recommended by the American College of Chest Physicians 5